Point of Care Testing Market to Reach US$66.68 Billion by 2031 as Demand for Rapid Diagnostics Accelerates
The global point of care testing market was valued at US$39.16 billion in 2024 and is projected to reach US$66.68 billion by 2031, registering a CAGR of 7.9% from 2025 to 2031.
The global point of care testing market is expanding as healthcare providers and patients increasingly seek rapid diagnostic solutions that can deliver results close to the patient. According to The Insight Partners, the market was valued at US$39.16 billion in 2024 and is expected to reach US$66.68 billion by 2031, registering a CAGR of 7.9% during 2025-2031. The report covers product categories including glucose monitoring, cardiometabolic testing, infectious disease testing, coagulation testing, pregnancy and fertility testing, urinalysis, and hematology.
Point of care testing enables diagnostic analysis in settings such as hospitals, clinics, laboratories, and homecare environments. The growing need for faster diagnostic results, increasing prevalence of chronic diseases, and advances in portable testing technologies are contributing to the expansion of the market.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPBT00002659
Rising Demand for Rapid Diagnostic Results Drives Market Growth
The increasing need for rapid diagnostic results is a major factor supporting the point of care testing market. Healthcare professionals require timely information to support clinical decisions, particularly in emergency care, primary care, and other settings where delays associated with conventional laboratory testing can affect workflow.
Point of care testing allows diagnostic procedures to be performed close to the patient, with results available within a comparatively short timeframe. This characteristic is contributing to adoption across different healthcare environments and supporting demand for increasingly accessible diagnostic technologies.
Growing Chronic Disease Burden Supports Testing Demand
The rising incidence of chronic diseases such as diabetes and cardiovascular disorders is creating sustained demand for monitoring and diagnostic solutions. Patients with chronic conditions often require regular testing to track relevant health parameters.
Point of care testing devices can support repeated monitoring in healthcare facilities as well as selected homecare environments. The ability to conduct testing closer to patients is contributing to broader adoption as healthcare systems seek convenient approaches for managing chronic conditions.
Glucose monitoring products are particularly important within this market. The report includes blood glucose-related products alongside cardiometabolic and other testing categories, reflecting the broad role of point of care technologies in chronic disease management.
Technological Advancements Improve Point of Care Testing
Technological innovation is transforming point of care testing by supporting the development of more portable, accurate, and user-friendly diagnostic devices. Advances in testing platforms are helping reduce dependence on centralized laboratory infrastructure and enabling diagnostic procedures to be performed in decentralized settings.
The report identifies technological advancements as one of the principal factors driving market growth. Improvements in testing technologies are particularly relevant to infectious disease management, chronic disease monitoring, and other applications where rapid access to diagnostic information is important.
User-Friendly Devices Create New Market Opportunities
The development of user-friendly point of care devices represents an important opportunity for manufacturers. As healthcare becomes increasingly decentralized, demand is growing for portable solutions that can be used in homes, remote locations, and other settings outside conventional laboratories.
Manufacturers are therefore focusing on devices designed around ease of use, portability, speed, and accuracy. Such developments can support broader deployment of diagnostic testing while addressing the requirements of healthcare professionals and patients.
AI and Machine Learning Open New Possibilities
The integration of artificial intelligence and machine learning represents another emerging opportunity for the point of care testing industry. AI and ML technologies can potentially support automated analysis of test results and provide additional information to healthcare professionals during the diagnostic process.
The Insight Partners identifies embedded AI and ML within point of care devices as an opportunity that could enhance diagnostic accuracy and enable real-time analysis. As these technologies mature, their integration into diagnostic platforms could create new avenues for product differentiation and innovation.
Emerging Markets Offer Expansion Potential
Expansion into emerging markets is another opportunity highlighted in the report. Healthcare access continues to develop across several emerging economies, creating demand for diagnostic technologies that can operate without the infrastructure requirements of large centralized laboratories.
Portable point of care testing platforms can support decentralized healthcare delivery in locations where access to sophisticated laboratory facilities may be limited. Market participants can therefore explore opportunities associated with healthcare infrastructure development and increasing demand for accessible diagnostic services.
Multiple Testing Platforms Support Market Development
The point of care testing market includes a diverse technology landscape. The report segments the market by platform into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays.
This technological diversity enables point of care testing to address different clinical requirements and sample types. Continued innovation across these platforms is expected to contribute to the development of faster, portable, and increasingly sophisticated diagnostic solutions.
Diagnosis Represents a Core Application
The market is segmented by application into research and development and diagnosis. Diagnostic applications represent an important part of point of care testing because the technology is designed to provide actionable test information close to the patient.
Point of care testing is used across hospitals, clinics, homecare environments, diagnostic laboratories, and other healthcare settings. The expansion of decentralized healthcare models is creating additional opportunities for testing technologies that can operate outside traditional laboratory environments.
North America Remains a Key Regional Market
North America is among the major geographical regions covered in the Point of Care Testing Market report. The regional analysis includes the US, Canada, and Mexico, while the broader study provides market analysis across Europe, Asia Pacific, South and Central America, and the Middle East and Africa.
The established healthcare infrastructure and continued adoption of advanced diagnostic technologies provide an important environment for point of care testing. At the same time, emerging healthcare markets across Asia Pacific and other regions provide opportunities for companies seeking geographic expansion.
Get Full Copy @ https://www.theinsightpartners.com/buy/TIPBT00002659
Market Segmentation
The global point of care testing market is segmented by product, platform, application, end user, and geography.
By product, the market includes glucose monitoring products, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, urinalysis testing products, and hematology testing products.
By platform, the market covers lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays.
By application, the market is divided into research and development and diagnosis.
By end user, the market includes hospitals and clinics, homecare, diagnostic laboratories, and others. The geographic scope covers North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa.
Competitive Landscape
The competitive landscape includes major diagnostics, healthcare technology, and medical device companies. Companies profiled in the report include F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthcare GmbH, Danaher, BD, Johnson & Johnson Private Limited, Chembio Diagnostics, Quidel Corporation, EKF Diagnostics, Trinity Biotech, AccuBioTech, Nova Biomedical, PTS Diagnostics, Instrumentation Laboratory Company, and Sekisui Diagnostic.
Competition in the market is influenced by product development, technological innovation, expansion of testing applications, portability, connectivity, and the ability to address changing requirements across hospitals, laboratories, and homecare environments.
Future Outlook
The global point of care testing market is projected to grow from US$39.16 billion in 2024 to US$66.68 billion by 2031, representing a CAGR of 7.9% during 2025-2031.
Rapid diagnostic requirements, the increasing burden of chronic diseases, technological advancements, user-friendly devices, AI and ML integration, and expansion into emerging markets are expected to remain important areas of market development.
The continued shift toward decentralized healthcare is also expected to support demand for portable and accessible testing solutions. As manufacturers develop more sophisticated platforms across molecular diagnostics, microfluidics, immunoassays, lateral flow assays, and other technologies, point of care testing is expected to remain an important component of modern diagnostic workflows.
About Us
The Insight Partners, we provide comprehensive analysis and insights into market trends that empower businesses to make informed decisions. Our reports are designed to equip stakeholders with the necessary information to navigate the complexities of various industries, including healthcare, technology, and finance. We are dedicated to delivering high-quality research that enables our clients to achieve their strategic objectives.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
